101 related articles for article (PubMed ID: 20967219)
1. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
Whitaker HC; Kote-Jarai Z; Ross-Adams H; Warren AY; Burge J; George A; Bancroft E; Jhavar S; Leongamornlert D; Tymrakiewicz M; Saunders E; Page E; Mitra A; Mitchell G; Lindeman GJ; Evans DG; Blanco I; Mercer C; Rubinstein WS; Clowes V; Douglas F; Hodgson S; Walker L; Donaldson A; Izatt L; Dorkins H; Male A; Tucker K; Stapleton A; Lam J; Kirk J; Lilja H; Easton D; ; ; ; Cooper C; Eeles R; Neal DE
PLoS One; 2010 Oct; 5(10):e13363. PubMed ID: 20967219
[TBL] [Abstract][Full Text] [Related]
2. MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.
Sutcliffe S; De Marzo AM; Sfanos KS; Laurence M
Prostate; 2014 May; 74(6):569-78. PubMed ID: 24464504
[TBL] [Abstract][Full Text] [Related]
3. Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts.
Lou H; Li H; Yeager M; Im K; Gold B; Schneider TD; Fraumeni JF; Chanock SJ; Anderson SK; Dean M
Hum Genet; 2012 Sep; 131(9):1453-1466. PubMed ID: 22661295
[TBL] [Abstract][Full Text] [Related]
4. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
6. Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancer.
Killick E; Bancroft E; Kote-Jarai Z; Eeles R
Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):545-55. PubMed ID: 22682955
[TBL] [Abstract][Full Text] [Related]
7. Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.
Principe S; Kim Y; Fontana S; Ignatchenko V; Nyalwidhe JO; Lance RS; Troyer DA; Alessandro R; Semmes OJ; Kislinger T; Drake RR; Medin JA
J Proteome Res; 2012 Apr; 11(4):2386-96. PubMed ID: 22339264
[TBL] [Abstract][Full Text] [Related]
8. Zinc stable isotopes in urine as diagnostic for cancer of secretory organs.
Schilling K; Moore RET; Sullivan KV; Capper MS; Rehkämper M; Goddard K; Ion C; Coombes RC; Vesty-Edwards L; Lamb AD; Halliday AN; Larner F
Metallomics; 2021 May; 13(5):. PubMed ID: 33877364
[TBL] [Abstract][Full Text] [Related]
9. Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics.
Desai TA; Hedman ÅK; Dimitriou M; Koprulu M; Figiel S; Yin W; Johansson M; Watts EL; Atkins JR; Sokolov AV; Schiöth HB; Gunter MJ; Tsilidis KK; Martin RM; Pietzner M; Langenberg C; Mills IG; Lamb AD; Mälarstig A; Key TJ; ; Travis RC; Smith-Byrne K
medRxiv; 2023 Sep; ():. PubMed ID: 37790472
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism within chromosome 8q24 is associated with prostate cancer development in Saudi Arabia.
Osman AE; Alharbi S; Ahmed AA; Elbagir AA
Asian J Urol; 2024 Jan; 11(1):26-32. PubMed ID: 38312824
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of
Chen X; Li H; Liu B; Wang X; Zhou W; Wu G; Xu C
Am J Cancer Res; 2023; 13(4):1582-1593. PubMed ID: 37168344
[TBL] [Abstract][Full Text] [Related]
12. Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response.
Ho-Plágaro A; Rodríguez-Díaz C; Santiago-Fernández C; López-Gómez C; García-Serrano S; Martín-Reyes F; Rodríguez-Pacheco F; Rodríguez-Cañete A; Alcaín-Martínez G; Vázquez-Pedreño L; Valdés S; Garrido-Sánchez L; García-Fuentes E
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625760
[TBL] [Abstract][Full Text] [Related]
13. Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.
Lonergan PE; Vertosick EA; Assel M; Sjoberg DD; Haese A; Graefen M; Boorjian SA; Klee GG; Cooperberg MR; Pettersson K; Routila E; Vickers AJ; Lilja H
BJU Int; 2021 Aug; 128(2):218-224. PubMed ID: 33306251
[TBL] [Abstract][Full Text] [Related]
14. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
[TBL] [Abstract][Full Text] [Related]
15. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
Dai JY; Wang X; Wang B; Sun W; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Feng Z; Stanford JL
PLoS Genet; 2020 Mar; 16(3):e1008667. PubMed ID: 32226005
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
Bicak M; Wang X; Gao X; Xu X; Väänänen RM; Taimen P; Lilja H; Pettersson K; Klein RJ
Hum Mol Genet; 2020 Jun; 29(10):1581-1591. PubMed ID: 32065238
[TBL] [Abstract][Full Text] [Related]
18. Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study.
Shrivastava P; Garg H; Bhat M; Dinda A; Kumar R
Indian J Urol; 2020; 36(1):50-55. PubMed ID: 31983827
[TBL] [Abstract][Full Text] [Related]
19. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Berglund E; Maaskola J; Schultz N; Friedrich S; Marklund M; Bergenstråhle J; Tarish F; Tanoglidi A; Vickovic S; Larsson L; Salmén F; Ogris C; Wallenborg K; Lagergren J; Ståhl P; Sonnhammer E; Helleday T; Lundeberg J
Nat Commun; 2018 Jun; 9(1):2419. PubMed ID: 29925878
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
